Hepatitis C virus free-virion and immune-complex dynamics during interferon therapy with and without ribavirin in genotype-1b chronic hepatitis C patients

Journal of Viral Hepatitis

Volumn 13, Issue 3, 2006, Pages 190-198

  Fujita, N ^a   Kaito, M ^a   Tanaka, H ^a   Horiike, S ^a   Urawa, N ^a   Sugimoto, R ^a   Konishi, M ^a   Watanabe, S ^b   Adachi, Y ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MIE UNIVERSITY   (Japan)

Author keywords

Humoral immunity; Immunoprecipitation; Interferon 2b; Real time detection PCR; Viral kinetics

Indexed keywords

ALPHA2B INTERFERON; RIBAVIRIN; VIRUS RNA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIGEN ANTIBODY COMPLEX; ANTIVIRAL ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC HEPATITIS; CLINICAL ARTICLE; DRUG POTENTIATION; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOPRECIPITATION; LIVER HISTOLOGY; MALE; MONOTHERAPY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; THROMBOCYTE COUNT; TREATMENT RESPONSE; VIRION; VIRUS TITRATION;

ADULT; AGED; ANTIGEN-ANTIBODY COMPLEX; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOPRECIPITATION; INTERFERON ALFA-2B; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBAVIRIN; RNA, VIRAL;

EID: 33645107808     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2005.00665.x     Document Type: Article

References (44)

1. Di Bisceglie AM Natural history of hepatitis C: its impact on clinical management Hepatology 2000 31 1014 1018
2. Hoofnagle JH Di Bisceglie AM The treatment of chronic viral hepatitis N Engl J Med 1997 336 347 356
3. McHutchison JG Gordon SC Schiff ER et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C N Engl J Med 1998 339 1485 1492
4. Davis GL Esteban-Mur R Rustgi V et al. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C N Engl J Med 1998 339 1493 1499
5. Poynard T Marcellin P Lee SS et al. Randomized trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus Lancet 1998 352 1426 1432
6. Sidwell RW Huffman P Khare L et al. Broad spectrum antiviral activity of virazole: 1-beta-D-ribofuranosyl-1, 2, 4-triazole-3-carboxamide Science 1972 177 705 706
7. McCormick JB King IJ Webb PA et al. Lassa fever. Effective therapy with ribavirin N Engl J Med 1986 314 20 26
8. Swedish consensus group Management of infections caused by respiratory syncytial virus Scand J Infect Dis 2001 33 323 328
9. Reichard O Anderson J Schwarcz R Weiland O Ribavirin treatment for chronic hepatitis C Lancet 1991 337 1058 1061
10. Di Bisceglie AM Conjeevaram HS Fried MW et al. Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial Ann Intern Med 1995 123 897 903
11. Bodenheimer HC Jr. Lindsay KL Davis GL Lewis LH Thung SN Seeff LB Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trail Hepatology 1997 26 473 477
12. Hultgren C Milich DR Weiland O Sallberg M The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses J Gen Virol 1998 79 2381 2391
13. Tam RC Pai B Band J et al. Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile J Hepatol 1999 30 376 382
14. Lam NP Neumann AU Gretch DR Wiley TE Perelson AS Layden TJ Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa Hepatology 1997 26 226 231
15. Neumann AU Lam NP Dahari H et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-α therapy Science 1998 282 103 107
16. Zeuzem S Herrmann E Lee JH et al. Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon-α 2a Gastroenterology 2001 120 1438 1447
17. Zeuzem S Schmidt JM Lee JH Ruster B Roth WK Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo Hepatology 1996 23 226 231
18. Layden TJ Layden LE Reddy KR Levy-Drummer RS Poulakos J Neumann AU Induction therapy with consensus interferon (CIFN) does not improve sustained virologic response in chronic hepatitis C J Viral Hepat 2002 9 334 339
19. Zeuzem S Schmidt JM Lee JH von Wagner M Teuber G Roth WK Hepatitis C virus dynamics in vivo: effects of ribavirin and interferon-alfa on viral turnover Hepatology 1998 28 245 252
20. Pawlotsky JM Dahari H Neumann AU et al. Antiviral action of ribavirin in chronic hepatitis C Gastroentrology 2004 126 703 714
21. Bradley D McCaustland K Krawczynski K Spelbring J Humphrey C Cook EH Hepatitis C virus: buoyant density of the factor VIII-derived isolate in sucrose J Med Virol 1991 34 206 208
22. Kaito M Watanabe S Tsukiyama-Kohara K et al. Hepatitis C virus particle detected by immunoelectron microscopic study J Gen Virol 1994 75 1755 1760
23. Ishida S Kaito M Kohara M et al. Hepatitis C virus core particle detected by immunoelectron microscopy and optical rotation technique Hepatol Res 2001 20 335 347
24. Maillard P Krawcznski K Nitkiewicz J et al. Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients J Virol 2001 75 8240 8250
25. Choo SH So HS Cho JM Ryu WS Association of hepatitis C virus particles with immunoglobulin: a mechanism for persistent infection J Gen Virol 1995 76 2337 2341
26. Murphy BR Chanock RM Immunization against viruses In Fields BN Knipe DM eds Fields Virology 2nd edn New York Raven Press 1990 469 496
27. Kohara M Tanaka T Tsukiyama-Kohara K et al. Hepatitis C virus genotypes 1 and 2 respond to interferon-α with different virologic kinetics J Infect Dis 1995 172 934 938
28. Neumann AU Lam NP Dahari H et al. Differences in viral dynamics between genotypes 1 and 2 hepatitis C virus J Infect Dis 2000 182 28 35
29. Fujita N Kaito M Takeo M et al. Different HCV dynamics of free-virions and immune-complexes after initiation of interferon-α in patients with chronic hepatitis C J Hepatol 2003 39 1013 1019
30. Desmet VJ Gerber M Hoofnagle JH Manns M Scheuer PJ Classification of chronic hepatitis: diagnosis, grading and staging Hepatology 1994 19 1513 1520
31. Fujita N Kaito M Takeo M et al. Non-immune complexed HCV RNA titre in serum as a predictor of interferon response in patients with chronic hepatitis C Am J Gastroenterol 2003 98 645 652
32. Fujita N Kaito M Ishida S et al. Paraformaldehyde protects of hepatitis C virus particles during ultracentrifugation J Med Virol 2001 63 108 116
33. Takeuchi T Katsume A Tanaka T et al. Real-time detection system for quantification of hepatitis C virus genome Gastroenterology 1999 116 636 642
34. Sintchak MD Nimmesgern E The structure of inosine 5′-monophosphate dehydrogenase and the design of novel inhibitors Immunopharmacology 2000 47 163 184
35. Toltzis P Huang AS Effect of ribavirin on macromolecular synthesis in vesicular stomatitis virus-infected cells Antimicrob Agents Chemother 1986 29 1010 1016
36. Patterson JL Femadez LR Molecular action of ribavirin Rev Infect Dis 1990 12 1132 1146
37. Crotty S Maag D Arnold JJ et al. The broad-spectrum antiviral ribonucleoside ribavirin in an RNA virus mutagen Nat Med 2000 6 1375 1379
38. Lertora JJ Rege AB Lacour JT et al. Pharmacokinetics and long-term tolerance to ribavirin in asymptomatic patients infected with human immunodeficiency virus Clin Pharmacol Ther 1991 50 442 449
39. Martin J Navas S Quiroga JA Pardo M Carreno V Effects of the ribavirin-interferon alpha combination on cultured peripheral blood mononuclear cells from chronic hepatitis C patients Cytokine 1998 10 635 644
40. Zeuzem S Lee JH Franke A et al. Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa Hepatology 1998 27 1149 1156
41. Castro FJ Esteban JI Juarez A et al. Early detection of nonresponse to interferon plus ribavirin combination treatment of chronc hepatitis C J Viral Hepat 2002 9 202 207
42. Chander G Sulkowski MS Jenckes MW et al. Treatment of chronic hepatitis C: a systematic review Hepatology 2002 36 S135 S144
43. Alberti A Benvegnu L Management of hepatitis C J Hepatol 2003 38 104 118
44. Herrmann E Lee JH Marinos G Modi M Zeuzem S Effect of ribavirin on hepatitis C viral kinetics in patients treated with pegylated interferon Hepatology 2003 37 1351 1358